# New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia

> **NCT00670150** · PHASE2 · WITHDRAWN · sponsor: **University of Southern California**

## Conditions studied

- Acute Promyelocytic Leukemia

## Interventions

- **DRUG:** NRX 195183 (retinoid analogue)
- **DRUG:** Arsenic Trioxide

## Key facts

- **NCT ID:** NCT00670150
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-05
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** sponsor withdrew support
- **Last updated:** 2015-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00670150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00670150, "New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00670150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*